ArticleFrontiers in pharmacology2025
Adverse event profile of lomustine and temozolomide: a descriptive analysis from WHO-VigiAccess.
Hua Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it